Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RTIX > SEC Filings for RTIX > Form 8-K on 12-Jun-2013All Recent SEC Filings

Show all filings for RTI BIOLOGICS, INC. | Request a Trial to NEW EDGAR Online Pro



Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure

On June 12, 2013, RTI Biologics, Inc., a Delaware Corporation ("RTI" or the "Company") held a conference call with investors, analysts and other interested parties to provide supplemental information regarding the Merger (as defined below). The conference call was pre-announced and was available to the public through live teleconference. A transcript of the conference call is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

The information in Item 7.01 of this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 8.01 Other Events

On June 12, 2013, RTI issued a press release announcing the execution of an Agreement and Plan of Merger (the "Merger Agreement") by and among the Company, Rockets MI Corporation, a Michigan corporation and wholly-owned subsidiary of the Company ("Merger Sub"), Pioneer Surgical Technology, Inc., a Michigan corporation ("Pioneer") and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as Stockholders' Agent, pursuant to which the Company will acquire Pioneer through the merger of Merger Sub with and into Pioneer (the "Merger"). In connection with the Merger, RTI received a commitment (the "Commitment") from TD Bank, N.A., a national banking association, as administrative agent for the Lenders (in such capacity, including any successor thereto), TD Securities "USA" LLC, as bookrunner and joint lead arranger, Regions Bank, as joint lead arranger, and each of the Lenders. Additionally, in connection with the Merger, RTI entered into an investment agreement dated as of June 12, 2013 (the "Investment Agreement") with WSHP Biologics Holdings, LLC, a Delaware limited liability company.

The Company is filing as Exhibit 99.3 attached hereto slides, which are incorporated herein by reference, that RTI anticipates making available on its website and using in connection with discussing the Merger with investors, analysts, employees and other interested parties.

The material terms of the Merger Agreement, Commitment and Investment Agreement, will be described in a subsequent filing on Form 8-K.

The full text of the press release is attached hereto as Exhibit 99.2 and is incorporated herein in its entirety by reference.


This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). In addition, these statements are subject to risks associated with the Pioneer's financial condition, business and operations and the integration of Pioneer's business with ours. Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting RTI's website at or the SEC's website at

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

   Exhibit 99.1   Transcript of conference call of RTI Biologics, Inc. dated June 12, 2013.

   Exhibit 99.2   Press release, dated June 12, 2013.

   Exhibit 99.3   Investor Presentation Slides, dated June 12, 2013.

  Add RTIX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RTIX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.